Storia in 4 fonti

Boots set to snub stock market return as it eyes £7.5bn sale

Boots' owner Sycamore Partners is in discussions with potential buyers including the family behind Primark as well as Australian pharmacists Sigma Healthcare.

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

thisismoney.co.ukStai leggendo1 mese fa

Boots set to snub stock market return as it eyes £7.5bn sale

Boots' owner Sycamore Partners is in discussions with potential buyers including the family behind Primark as well as Australian pharmacists Sigma Healthcare.

originale

Timeline cronologica

martedì 9 giugno 2026·thisismoney.co.uk
Boots set to snub stock market return as it eyes £7.5bn sale
Boots' owner Sycamore Partners is in discussions with potential buyers including the family behind Primark as well as Australian pharmacists Sigma Healthcare.
mercoledì 10 giugno 2026·afr.com
Chemist Warehouse owner in talks over $14b Boots sale: FT
ASX-listed Sigma Healthcare is looking at Boots alongside other bidders including Canada’s wealthy Weston family, the report said.

Boots set to snub stock market return as it eyes £7.5bn sale

Confronto fonti

Boots set to snub stock market return as it eyes £7.5bn sale

Timeline cronologica

Boots set to snub stock market return as it eyes £7.5bn sale

Chemist Warehouse owner in talks over $14b Boots sale: FT

Sycamore negocia la venta de la cadena de farmacias Boots por 8.660 millones

Australia’s Sigma confirms talks over Boots takeover

Chemist Warehouse owner in talks over $14b Boots sale: FT

Chemist Warehouse’s owner Sigma bankers up to weigh bid for UK’s Boots

Australia’s Sigma confirms talks over Boots takeover

Sycamore negocia la venta de la cadena de farmacias Boots por 8.660 millones